Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell

Author's Avatar
Sep 13, 2019
Article's Main Image

Castle Creek will advance multiple late-stage clinical development programs targeting epidermolysis bullosa

PR Newswire